Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Placex is a pharmaceutical product developed and marketed by Megat Pharmaceutical, an Ecuadorian company. The active ingredient is placenta extract, a complex biologic substance derived from placental tissue that is rich in growth factors (such as Epidermal Growth Factor and Fibroblast Growth Factor), cytokines, vitamins, and amino acids. Placex is primarily indicated for the treatment of various types of alopecia (hair loss) and for skin revitalization or anti-aging treatments. It functions by stimulating cellular metabolism, promoting fibroblast proliferation, and enhancing collagen synthesis through the activation of specific growth factor receptors. In clinical practice, it is typically administered via topical application or intradermal injection (mesotherapy) to target the scalp or skin tissues directly, facilitating tissue repair and regeneration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Placex.